Post-ECT Hyperthermia and Rapid Mood Improvements: a Case Report

Antosik-Wójcińska, Anna; Bzinkowska, Dorota; Święcicki, Łukasz; Bieńkowski, Przemysław

doi:10.1176/appi.neuropsych.13020042

Cited by 5 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Однако анализ истории свидетельствует, что это утверждение верно только для нашей страны, и то лишь отчасти. Некоторые представители ИМАО продолжают использоваться во многих странах Европы и Америки (фенелзин, транилципромин, изокарбоксазид) [62,63]. В последние десятилетия высказывается точка зрения о завышении степени риска развития тираминового синдрома при лечении ИМАО (табл.…”

Section: Chronology Of the Creation And Introduction Into Practice Of...unclassified

Evolution of ideas about the risk of tyramine syndrome developing during therapy with irreversible non-selective monoamine oxidase inhibitors (to the 70th anniversary of the first use of this group of antidepressants)

Данилов¹,

Brovko

2022

RJTAO

View full text Add to dashboard Cite

We describe the history of studying of the problem of tyramine syndrome during the treatment with antidepressants, irreversible non-selective monoamine oxidase inhibitors. Data on clinical observations are presented. Early hypotheses of pathogenesis are considered. The period of discovery of the relationship between increased blood pressure and the use of foods containing tyramine is outlined. The transformation of terminology is demonstrated. The events associated with the restriction of the use of therapy are characterized. The formation of the opinion about the exaggeration of the risk of developing tyramine syndrome is analyzed. Data on the involvement in the discussion of the problem of tyramine syndrome of society as a whole are given.

show abstract